Borosil Scientific Total Liabilities
Borosil Scientific total liabilities. Based on the latest financial reports, Borosil Scientific (BOROSCI) has total liabilities worth Rs1.08 Billion INR (≈ $11.64 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BOROSCI defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Borosil Scientific (2022–2026)
Total liabilities of Borosil Scientific from 2022 to 2026. This chart illustrates how Borosil Scientific's total liabilities have evolved over time, based on quarterly financial data. Check BOROSCI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Borosil Scientific Competitors by Total Liabilities
The table below lists competitors of Borosil Scientific ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Emeren Group Ltd
NYSE:SOL
|
USA | $125.97 Million |
|
We&Win Diversification Co Ltd
TWO:4113
|
Taiwan | NT$12.42 Billion |
|
Dyaco International Inc
TW:1598
|
Taiwan | NT$5.20 Billion |
|
Dhunseri Ventures Limited
NSE:DVL
|
India | Rs11.30 Billion |
|
Christiani & Nielsen (Thai) Public Company Limited
BK:CNT
|
Thailand | ฿6.02 Billion |
|
Kencana Agri Limited
F:KEBA
|
Germany | €206.68 Million |
|
Taiwan Takisawa Technology Co Ltd
TWO:6609
|
Taiwan | NT$1.05 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩145.87 Billion |
Liability Composition Analysis (2022–2026)
This chart breaks down Borosil Scientific's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BOROSCI current and non-current assets.
Liquidity & Leverage Metrics
Borosil Scientific Total Liabilities Ratios Explained
Borosil Scientific total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Borosil Scientific's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Borosil Scientific (2022–2026)
The table below shows the annual total liabilities of Borosil Scientific from 2022 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs1.08 Billion ≈ $11.64 Million |
+3.12% |
| 2025-03-31 | Rs1.04 Billion ≈ $11.28 Million |
-10.82% |
| 2024-03-31 | Rs1.17 Billion ≈ $12.65 Million |
+76.21% |
| 2023-03-31 | Rs663.92 Million ≈ $7.18 Million |
+217.79% |
| 2022-03-31 | Rs208.91 Million ≈ $2.26 Million |
-- |
About Borosil Scientific
Borosil Scientific Limited engages in the manufacture and sale of laboratory glassware. It offers glassware and consumables, including lab glassware, filtration products, and analytical vials; laboratory instrumentation for use in nutrition and environment, life essentials, life sciences, and liquid handling; pharmaceutical primary packaging materials, such as glass ampoules and tubular glass via… Read more